The two sessions of the proposal | multi-level attention to the inheritance and sustainable development of traditional Chinese medicine

Release time:

2024-03-15


Chinese medicine is the treasure of the Chinese nation. Inheriting and developing the cause of traditional Chinese medicine and stimulating the vitality of the cause of traditional Chinese medicine requires enterprise self-improvement, government support and social attention.

 

Chairman of Jiangsu Qiuqi Natural Pharmaceutical Co., Ltd., Jinshan brand Zhenjiang plaster production technology "intangible cultural heritage" protection inheritor--Geng Tongquan

 

Chinese medicine is the treasure of the Chinese nation. Inheriting and developing the cause of traditional Chinese medicine and stimulating the vitality of the cause of traditional Chinese medicine requires enterprise self-improvement, government support and social attention.

As a practitioner who has been struggling in the Chinese medicine industry since 1985, I have experienced various changes in the Chinese medicine industry. I have seen this industry through the precipitation of history, and I am full of new vitality in the current era. Taking the traditional Chinese medicine leading product "Jinshan Brand" Zhenjiang Plaster of Jiangsu Seven Natural Pharmaceutical Co., Ltd. as an example, this paper puts forward personal suggestions for the inheritance and development of traditional Chinese medicine.

"Jinshan brand" Zhenjiang plaster is one of the typical representatives of traditional Chinese medicine-black plaster. From the perspective of its inheritance, ointment is one of the traditional dosage forms of Chinese medicine in my country. It has been recorded in medical documents such as "Huangdi Neijing" and "Shennong Bencao Jing" during the Warring States Period. The black plaster originated from the prevalence of alchemy in the Wei and Jin Dynasties, and its preparation process was gradually improved in the Tang and Song Dynasties. The black plaster was widely used in the Ming and Qing Dynasties and became a common medication for the people. As far as the product itself is concerned, the "Jinshan Brand" Zhenjiang Plaster has been passed down for more than 360 years. It is a traditional medicine business card and "gold-lettered signboard" in Jiangsu Province ".

Until 2023, our company has been using traditional production techniques for the production of Zhenjiang plaster. Taking manual spreading as an example, the cost of training professional and technical personnel, the labor cost of manual spreading and the time-consuming cost are very large.

In order to comply with the requirements of the times, reduce labor intensity, improve production efficiency, ensure stable product quality and meet market demand, the company spent eight years working with universities, related enterprises and equipment manufacturers to develop new mounting materials and Zhenjiang paste spread molding integrated production equipment, and passed GMP compliance inspection in December 2023. At present, the use of new equipment production of new Zhenjiang plaster has been officially put on the market, has received a good response.

In my opinion, through the efforts of enterprises themselves, on the basis of inheriting and protecting the traditional culture of traditional Chinese medicine, with the help of modern science and technology, the traditional Chinese medicine culture accumulated over the past thousand years can be continuously revitalized, and precious traditional Chinese medicine products can flow in the market, which is the real protection for the cause and products of traditional Chinese medicine.

Up to a few days ago, the state has issued a series of policy documents, which provide policy basis and implementation path for the characteristic development and revitalization of traditional Chinese medicine. Under the promotion of local governments, industry associations and other parties, our company has set up a special school of traditional Chinese medicine, which is regularly open to primary and secondary school students to help popularize the knowledge of traditional Chinese medicine and inherit the cause of traditional Chinese medicine. I hope that through my efforts, I will plant the seeds of interest for the children and guide more people to pay attention to the Chinese medicine industry.

Inherit the essence and keep innovation. As the "Jinshan brand" Zhenjiang plaster production technology "intangible cultural heritage" protection inheritor, I have realized the improvement of "intangible cultural heritage" product quality and output through the implementation of the modernization of the production line, and accelerated the development of new quality productivity. People understand Zhenjiang plaster and relieve the pain of more patients.

The good operation of enterprises can not be separated from the government policy support and marketing. As we all know, many "intangible cultural heritage" products of traditional Chinese medicine have no chance to enter the "National Medical Insurance Catalog", so they cannot keep up with the pace of modern marketing. They can only stay in the museum and tell the story of the past through the commentator. The company feels helpless and faces difficulties. In today's pharmaceutical management system and business environment, it is suggested that more "intangible cultural heritage" products of traditional Chinese medicine with "exact curative effect, clinical necessity, safety and effectiveness, and reasonable price" should be transferred into the national medical insurance catalogue, so that they can really enter medical institutions and enter the pharmaceutical market, so as to achieve sustainable and high-quality development. Making more "intangible cultural heritage" products of traditional Chinese medicine better connect with modern society and benefit more patients is a realistic issue that the medical and medical insurance authorities of governments at all levels must face squarely and solve.

In addition, in the face of the increasingly depleted resources of wild Chinese medicinal materials, it is recommended to vigorously support, protect, supervise and encourage self-construction or joint construction with growers of Chinese medicinal materials production enterprises and production bases that meet GAP requirements, so that Chinese medicinal materials production enterprises and Chinese medicinal materials production enterprises Become a real community of interests, extend the drug quality management system to the origin of Chinese medicinal materials, and lay the foundation for high-quality Chinese medicine products.

In the future, Jiangsu Qi07 Natural Pharmaceutical Co., Ltd. will continue to increase investment, devote itself to making good medicines for the country, and continue to strive for the construction of a healthy China.